Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Gross Margin (2016 - 2025)

Surgery Partners (SGRY) has disclosed Gross Margin for 12 consecutive years, with 149.53% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 462.0% to 149.53% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 93.91% through Dec 2025, down 948.0% year-over-year, with the annual reading at 93.91% for FY2025, 39.0% up from the prior year.
  • Gross Margin hit 149.53% in Q4 2025 for Surgery Partners, up from 74.57% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 151.14% in Q4 2022 to a low of 71.22% in Q1 2022.
  • Historically, Gross Margin has averaged 87.14% across 5 years, with a median of 73.44% in 2023.
  • Biggest five-year swings in Gross Margin: surged 7924bps in 2022 and later crashed -7768bps in 2023.
  • Year by year, Gross Margin stood at 71.89% in 2021, then soared by 110bps to 151.14% in 2022, then crashed by -51bps to 73.46% in 2023, then surged by 97bps to 144.91% in 2024, then grew by 3bps to 149.53% in 2025.
  • Business Quant data shows Gross Margin for SGRY at 149.53% in Q4 2025, 74.57% in Q3 2025, and 73.98% in Q2 2025.